BIOMAT Database Logo BIOMAT Database Logo

Methotrexate induced early onset pancytopenia in rheumatoid arthritis: drug allergy? Idiosyncrasy? 1992

Y Tanaka, and K Shiozawa, and Y Nishibayashi, and S Imura

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010198 Pancytopenia Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets. Pancytopenias
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

Y Tanaka, and K Shiozawa, and Y Nishibayashi, and S Imura
Methotrexate-associated, early-onset pancytopenia in rheumatoid arthritis.
June 1989, Archives of internal medicine,
Y Tanaka, and K Shiozawa, and Y Nishibayashi, and S Imura
Pancytopenia induced by low-dose methotrexate for rheumatoid arthritis.
August 1988, Australian and New Zealand journal of medicine,
Y Tanaka, and K Shiozawa, and Y Nishibayashi, and S Imura
Pancytopenia in rheumatoid arthritis patients receiving methotrexate.
May 1996, Revue du rhumatisme (English ed.),
Y Tanaka, and K Shiozawa, and Y Nishibayashi, and S Imura
[Pancytopenia in rheumatoid arthritis treated with methotrexate].
September 1996, Presse medicale (Paris, France : 1983),
Y Tanaka, and K Shiozawa, and Y Nishibayashi, and S Imura
Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis.
February 1996, Arthritis and rheumatism,
Y Tanaka, and K Shiozawa, and Y Nishibayashi, and S Imura
[Drug allergy and idiosyncrasy].
September 1968, Terapevticheskii arkhiv,
Y Tanaka, and K Shiozawa, and Y Nishibayashi, and S Imura
Pancytopenia related eosinophilia in rheumatoid arthritis: a specific methotrexate phenomenon?
July 1995, The Journal of rheumatology,
Y Tanaka, and K Shiozawa, and Y Nishibayashi, and S Imura
[Pancytopenia and opportunistic infections in rheumatoid arthritis treated with methotrexate].
September 1990, Revista clinica espanola,
Y Tanaka, and K Shiozawa, and Y Nishibayashi, and S Imura
Acute parvovirus B19-induced pancytopenia in the setting of methotrexate therapy for rheumatoid arthritis.
July 1995, Arthritis and rheumatism,
Y Tanaka, and K Shiozawa, and Y Nishibayashi, and S Imura
How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
December 2018, Clinical rheumatology,
Copied contents to your clipboard!